We are live on !
Find out more
DA
DCF Advisers Portfolio holdings
AUM
$566M
Turnover
17.35%
1-Year Est. Return
197.74%
This Fund
S&P 500
This Quarter Est. Return
+96.59%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$566M
AUM Growth
+$191M
(+51%)
Cap. Flow
-$25.1M
Cap. Flow % of AUM
Cap. Flow %
-4.43%
Top 10 Holdings %
Top 10 Hldgs %
65.92%
Holding
98
New
12
Increased
27
Reduced
22
Closed
5
Avg Time Held
Equity + Options
2.4
years
Top 10 Avg Time Held
Equity + Options
2
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
2.8
years
Top 10 Avg Time Held Equity only
2.3
years
Top 20 Avg Time Held Equity only
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$5.33M |
| 2 |
HELP
Helus Pharma Inc. Common Stock
HELP
|
+$3.72M |
| 3 |
Microsoft
MSFT
|
+$3.33M |
| 4 |
Immuneering
IMRX
|
+$3.28M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$37.5M |
| 2 |
Eli Lilly
LLY
|
+$5.72M |
| 3 |
Cisco
CSCO
|
+$1.57M |
| 4 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$1.52M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$1.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.15% |
| 2 | Technology | 31.31% |
| 3 | Healthcare | 17.63% |
| 4 | Communication Services | 4.62% |
| 5 | Consumer Discretionary | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
uniQure
QURE
$1.73B
| $1.84M | 0.33% |
40,000
-9,000
| -18% | -$236K |
2026 Q1
1 quarter
|
|
52
Sprott Uranium Miners ETF
URNM
$1.8B
| $1.84M | 0.33% |
35,000
| – | – |
2024 Q2
8 quarters
|
|
53
Structure Therapeutics
GPCR
$1.53B
| $1.72M | 0.3% |
32,100
+4,600
| +17% | +$204K |
2025 Q4
2 quarters
|
|
54
Xencor
XNCR
$2.23B
| $1.67M | 0.3% |
103,736
| – | – |
2019 Q4
26 quarters
|
|
55
Apple
AAPL
$5.02T
| $1.66M | 0.29% |
5,750
| – | – |
2019 Q4
26 quarters
|
|
56
Allot
ALLT
$451M
| $1.5M | 0.27% |
170,000
+13,500
| +9% | +$100K |
2025 Q1
5 quarters
|
|
57
KraneShares CSI China Internet ETF
KWEB
$4.27B
| $1.35M | 0.24% |
+55,000
| New | +$1.52M |
2026 Q2
0 quarters
|
|
58
Boeing
BA
$132B
| $1.3M | 0.23% |
+6,000
| New | +$1.33M |
2026 Q2
0 quarters
|
|
59
Qualcomm
QCOM
$195B
| $1.29M | 0.23% |
7,000
-3,250
| -32% | -$608K |
2019 Q4
26 quarters
|
|
60
Zai Lab
ZLAB
$2.59B
| $1.21M | 0.21% |
63,500
| – | – |
2024 Q2
8 quarters
|
|
61
Arq
ARQ
$80.8M
| $1.18M | 0.21% |
461,585
+133,782
| +41% | +$332K |
2025 Q4
2 quarters
|
|
62
Lyft
LYFT
$6.19B
| $1.14M | 0.2% |
78,000
-24,500
| -24% | -$343K |
2025 Q1
5 quarters
|
|
63
Meta Platforms (Facebook)
META
$1.59T
| $1.13M | 0.2% |
2,000
| – | – |
2022 Q1
17 quarters
|
|
64
CALL
Starbucks
SBUX
$118B
| $1.02M | 0.18% |
10,000
| – | – |
2025 Q4
2 quarters
|
|
65
iShares Russell 2000 ETF
IWM
$75.5B
| $901K | 0.16% |
3,000
| – | – |
2023 Q2
12 quarters
|
|
66
AstraZeneca
AZN
$263B
| $901K | 0.16% |
4,750
-1,000
| -17% | -$188K |
2025 Q4
2 quarters
|
|
67
SRH Total Return Fund
STEW
$1.74B
| $895K | 0.16% |
50,000
| – | – |
2019 Q4
26 quarters
|
|
68
Pinterest
PINS
$11.8B
| $841K | 0.15% |
40,000
+15,000
| +60% | +$301K |
2026 Q1
1 quarter
|
|
69
General Motors
GM
$70B
| $771K | 0.14% |
10,000
-2,500
| -20% | -$196K |
2025 Q4
2 quarters
|
|
70
Compass Pathways
CMPS
$1.7B
| $768K | 0.14% |
54,250
+11,750
| +28% | +$119K |
2026 Q1
1 quarter
|
|
71
Prothena Corp
PRTA
$467M
| $717K | 0.13% |
73,247
| – | – |
2021 Q1
21 quarters
|
|
72
Zenas BioPharma
ZBIO
$1.88B
| $715K | 0.13% |
+28,184
| New | +$560K |
2026 Q2
0 quarters
|
|
|
73
PUT
Amazon
AMZN
$2.75T
| $715K | 0.13% |
+3,000
| New | +$753K |
2026 Q2
0 quarters
|
|
74
PUT
Alphabet (Google) Class A
GOOGL
$3.97T
| $715K | 0.13% |
2,000
-17,000
| -89% | -$6.12M |
2025 Q4
2 quarters
|
|
75
Viridian Therapeutics
VRDN
$2.75B
| $698K | 0.12% |
38,000
+5,850
| +18% | +$94.3K |
2023 Q2
12 quarters
|
|
Similar funds
LT
DCF Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, DCF Advisers held 98 positions worth $566M, up 51% from $375M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
DCF Advisers withdrew a net $25.1M in Q2 2026, closing 5 positions and reducing 22 holdings. Its most notable exit was Synopsys, an estimated $496K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 38% a quarter earlier, followed by Technology and Healthcare.
Against the trend, DCF Advisers opened a new position in MarineMax worth $2.11M.
- DCF Advisers's largest Q2 2026 buy was MarineMax: 57,500 shares worth $2.11M.
- DCF Advisers added most to Amazon in Q2 2026, an estimated $5.33M increase.
- DCF Advisers's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $37.5M.
- DCF Advisers fully exited Synopsys in Q2 2026, selling an estimated $496K.
- DCF Advisers's ten largest holdings make up 66% of its $566M portfolio in Q2 2026.
- DCF Advisers opened 12 new positions and closed 5 in Q2 2026.
- DCF Advisers's portfolio value rose 51% quarter-over-quarter to $566M.
Based on DCF Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.